In a recent study, researchers found that treatment at ‘First Episode Mood and AnxietyProgram’ (FEMAP), a psychological state program for youth with mood and anxiety disorders, light-emitting diode to improved patient outcomes. The study was printed within the Journal of Early Intervention in psychological medicine. FEMAP provides treatment to rising adults, ages sixteen to twenty-five, with emotional issues that fall under the classes of mood and anxiety symptoms. The treatment takes a patient-centered approach in a very youth-friendly setting where patients receive care from a multidisciplinary team.
“FEMAP helped me to grasp that there wasn’t something wrong with me that I wasn’t alone within the method that I felt. I learned to cope and touch upon things in additional constructive ways that made things such a lot easier. Before coming into the program, I had trouble finishing school, no job prospects and couldn’t hold down a relationship. Now, 3 years out of the program, I even have an excellent job, am married and own a house, which are things I ne’er thought would be doable,” aforesaid analysis participant, Kirstie Leedham.
The study enclosed 370 youth. Before starting treatment, they were, on average, experiencing moderate depression, moderate anxiety and low satisfaction with their quality of health. Of 370 youth eligible for treatment, 322 attended a clinical assessment. The analysis team found that people who disengaged early had less severe symptoms than people who stayed engaged.
Follow-up questionnaires were completed by 174 youth more or less than six months into treatment. The analysis team discovered vital enhancements in patient outcomes, together with a discount in mood and anxiety symptoms, improved functioning and a higher quality of health satisfaction.
“These results demonstrate the effectiveness of early intervention programs providing personalized treatment that adjusts to patient’s needs and desires. The information suggests our model is successful in serving to patients manage their mood and anxiety disorders,” aforesaid Dr. Elizabeth Osuch, Clinician-Scientist.
“Our results counsel FEMAP provides access to psychological state care within the most applicable settings by preventing ED visits, demonstrating the health system potential of this novel treatment program,” notes Dr. Kelly Anderson, Associate Scientist.